SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : HEB, Hemispherx Biopharma (AMEX)NEW
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: robert marconato who wrote (47)11/14/1997 12:50:00 AM
From: MarcG   of 857
 
Gerry brought to our attention the fact
that new financing has been completed for now. I think what held HEB back was that uncertainty.
Many times with junior biotechs, it is the speculation of results that creates price momentum. LDAKA was a perfect example years back, rising from the penny stock ranks to NASDAQ ( reached a high of $9.00 ) on alot of speculation.
With an upcoming roadshow, starts the 19th, and possible brokerage sponsorship, there would seem to be the promise of more this time.
Also Robert,
people can make the difference.
Every time the stock came in ("slumped"), the volume was light. Watch the volume for a difference. HEB is lighting up many screens tonight,
including the AMEX, as the #4 stock on the best gainers list,
and many worldwide publications will also expose HEB's performance tomorrow morning.

amex.com.


MG:

Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News